Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 189 (ZNF189) is a member of the Krüppel-like family of zinc finger transcription factors characterized by tandem Cys2-His2 (C2H2) zinc finger motifs and an N-terminal KRAB domain for transcriptional repression. It binds DNA at specific response elements to regulate gene expression, often repressing genes by recruiting corepressor complexes through its KRAB domain. ZNF189 coordinates neuronal morphological maturation, regulates transposon-associated immune function, and is implicated in complex social behaviors in animal models. Although not a typical therapeutic target, ZNF189 plays important roles in transcriptional control and has been associated with cleft palate development. There are no known drugs or biomarker applications in clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 189 (ZNF189).